Chemical sympathetic denervation: promising, but important distinctions between agents and methods.
暂无分享,去创建一个
R. Virmani | S. Bertog | A. Pathak | H. Sievert | E. Ladich | K. Yahagi | L. Vaskelyte | V. Ghazarossian | Félix Vega
[1] Neil Chapman,et al. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial , 2017, The Lancet.
[2] R. Virmani,et al. Randomised, blinded and controlled comparative study of chemical and radiofrequency-based renal denervation in a porcine model. , 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[3] F. Ikeno,et al. Transcatheter Alcohol-Mediated Perivascular Renal Denervation With the Peregrine System: First-in-Human Experience. , 2016, JACC. Cardiovascular interventions.
[4] R. Virmani,et al. Anatomic assessment of sympathetic peri-arterial renal nerves in man. , 2014, Journal of the American College of Cardiology.
[5] Deepak L. Bhatt,et al. Refining calcium test for diagnosis of medullary thyroid cancer: cutoffs, procedures and safety , 2014, The New England journal of medicine.
[6] C. Tsioufis,et al. Chemical denervation of the renal artery with vincristine for the treatment of resistant arterial hypertension: first-in-man application. , 2013, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.